Belantamab mafodotin 70mg powder for solution for infusion vials
in short Belantamab mafodotin 70mg inf vials
- SNOMED code
45077311000001108- Active compound
- Belantamab mafodotin
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 vial, vial
- Ingredients
- Belantamab mafodotin
— 70 mg
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Powder for solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
Blenrep 70mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd)
in short Blenrep 70mg pdr for concentrate for inf vials
Blenrep 70mg powder for concentrate for solution for infusion vials
- SNOMED code
45014411000001102- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Blenrep 70mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial45014711000001108 ref. pack | 💯 Available Legal category: POM | 505429001208805054290012088 | NHS Indicative Price £11,784 previously: £8,248 | • Hospital |
| — |
Reference packs
Belantamab mafodotin 70mg powder for solution for infusion vials 1 vial
- SNOMED code
45014011000001106- Quantity and unit
- 1 vial
- Packs